Close
Clinical – Whole Body
Visualization of bone marrow (left femur in oblique sagittal view).
Case Report: Nonsecretory Multiple Myeloma MRI Monitoring of Therapy Response
Marius Horger, M.D.
University Hospital Tuebingen, Dept. of Diagnostic and Interventional Radiology, Tuebingen, Germany
Whole body imaging protocols are mandatory, especially for assessment of myeloma infiltration in all bone marrow cavities (medullary involvement) as well as for diagnosis of extramedullary involvement. These two myeloma manifestations can be displayed at best by joined multidetector Computed Tomography (MDCT) and MR imaging.
TimCT BLADE TIRM image selected from whole-body oncologic screening examinations.
Case Report: Whole-body Oncologic Imaging with syngo TimCT
Eric Hatfield, M.D.1; Agus Priatna, Ph.D.2; John Kotyk, Ph.D.1; Benjamin Tan, M.D.1;
Alto Stemmer3; Stephan Kannengiesser, Ph.D.3; Vamsi Narra, M.D.1
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA
2Siemens Healthcare, R&D Collaborations, St Louis, Missouri, USA
3Siemens Healthcare, MR PLM AW Oncology, Erlangen, Germany
Oncologic patients were invited to volunteer for whole-body MR imaging with syngo® TimCT Oncology and the above protocol. These images were compared with their prior routine imaging including FDG PET/CT, conventional contrastenhanced CT (ceCT) and conventional MR.
